PetLife Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Campbell Vyvyan, was filed 20 Mar 2018.
PetLife Pharmaceuticals, Inc.: what insiders have been doing
PetLife Pharmaceuticals, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). PetLife Pharmaceuticals, Inc. has had no insider filing for more than a year; the last one goes back to 20 March 2018.
Our records for PetLife Pharmaceuticals, Inc. go back to 2007, with 8 purchases and 1 sale on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -97.7%Entry US$0.39 · Close at T+365 US$0.01
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 305,000 shares@ US$0.013299.5% of flowCommon StockSEC:0001493152-18-003630:0Canonical exit: 29 May 2018 (T+90)
- 1,250,000 sharesCommon StockSEC:0001493152-18-002844:0
- 1,250,000 sharesSeries A Preferred StockSEC:0001493152-18-002844:1
- 1,000,000 sharesCommon StockSEC:0001493152-18-002842:1
- 1,000,000 sharesSeries A Preferred StockSEC:0001493152-18-002842:2
- 1,000,000 sharesCommon StockSEC:0001493152-18-002843:0
- 1,000,000 sharesSeries A Preferred StockSEC:0001493152-18-002843:1
- 1,000,000 shares@ US$0.67Common StockSEC:0001493152-18-002842:0
- 5,000,000 shares@ US$0.064.6% of flowCommon StockSEC:0001493152-18-002844:2
- 100,000 shares@ US$0.25Common StockSEC:0001493152-17-002852:0Canonical exit: 28 Mar 2016 (T+90)
- 250,000 shares@ US$0.64Common StockSEC:0001493152-17-002852:1Canonical exit: 12 May 2016 (T+90)
- 540,000 shares@ US$0.46Common StockSEC:0001493152-17-002852:2Canonical exit: 12 May 2016 (T+90)
- 11,160,000 shares@ US$0.5095.4% of flowCommon StockSEC:0001493152-17-002852:4
- 218,470 shares@ US$1.250.0% of flowCommon StockSEC:0001493152-17-002849:2Canonical exit: 13 Aug 2016 (T+90)
- 1,200,000 shares@ US$0.500.1% of flowCommon StockSEC:0001493152-17-002849:3
- 40,000 shares@ US$0.250.0% of flowCommon StockSEC:0001493152-17-002849:4Canonical exit: 24 May 2017 (T+90)
- 9,484,555 shares@ US$0.500.4% of flowCommon StockSEC:0001493152-17-002849:5
- 50,210 shares@ US$0.75Common StockSEC:0001493152-17-002849:0Canonical exit: 28 Aug 2015 (T+90)
- 100,000 shares@ US$0.25Common StockSEC:0001493152-17-002849:1Canonical exit: 7 Feb 2016 (T+90)
- 13,000,000 shares@ US$0.0004Shares of Common StockSEC:0001284834-07-000047:0
20 of 20 declarations
About PetLife Pharmaceuticals, Inc.
PetLife Pharmaceuticals, Inc. is a company focused on developing pharmaceutical products for pets. It is listed on NASDAQ under the ticker XNAS.
